Cite
MP18-03 TUMOR-INFILTRATING CD39+CD8+ T CELLS DETERMINE POOR PROGNOSIS AND IMMUNE EVASION IN CLEAR-CELL RENAL CELL CARCINOMA PATIENTS
MLA
Jianming Guo, et al. “Mp18-03 Tumor-Infiltrating Cd39+Cd8+ T Cells Determine Poor Prognosis and Immune Evasion in Clear-Cell Renal Cell Carcinoma Patients.” The Journal of Urology, vol. 203, Apr. 2020, pp. e234–35. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9c9ee0bc0df28fe78a9c52a37e7bd534&authtype=sso&custid=ns315887.
APA
Jianming Guo, Jiejie Xu, & Yu Qi. (2020). Mp18-03 Tumor-Infiltrating Cd39+Cd8+ T Cells Determine Poor Prognosis and Immune Evasion in Clear-Cell Renal Cell Carcinoma Patients. The Journal of Urology, 203, e234–e235.
Chicago
Jianming Guo, Jiejie Xu, and Yu Qi. 2020. “Mp18-03 Tumor-Infiltrating Cd39+Cd8+ T Cells Determine Poor Prognosis and Immune Evasion in Clear-Cell Renal Cell Carcinoma Patients.” The Journal of Urology 203 (April): e234–35. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........9c9ee0bc0df28fe78a9c52a37e7bd534&authtype=sso&custid=ns315887.